WVE - Wave Life Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.38
DETAILS
HIGH:
$43.00
LOW:
$13.00
MEDIAN:
$28.00
CONSENSUS:
$26.38
UPSIDE:
313.48%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 42.7 | 108.3 | 113.3 | 3.6 | 41.0 | 20.1 | 16.0 | 14.4 | 3.7 | 1.5 | 0.2 | 0 | 0 |
| Cost of Revenue | 8.9 | 0 | 0 | 0 | 0 | 130.9 | 175.4 | 134.4 | 79.3 | 0.4 | 9.1 | 2.4 | 4.6 |
| Gross Profit | 33.9 | 108.3 | 113.3 | 3.6 | 41.0 | (110.9) | (159.4) | (120.0) | (75.6) | 1.1 | (8.9) | (2.4) | (4.6) |
| Operating Expenses | |||||||||||||
| R&D Expenses | 182.8 | 159.7 | 130.0 | 115.9 | 121.9 | 130.9 | 175.4 | 134.4 | 79.3 | 40.8 | 9.1 | 2.4 | 1.9 |
| SG&A Expenses | 75.3 | 59.0 | 51.3 | 50.5 | 46.1 | 42.5 | 48.9 | 39.5 | 27.0 | 16.0 | 10.4 | 3.0 | 1.7 |
| Other Expenses | (8.9) | 0 | 0 | 0 | 0 | (130.9) | (175.4) | 9.5 | (0.3) | (0.1) | 0.1 | 0.3 | 0.0 |
| Operating Expenses | 249.3 | 218.7 | 181.3 | 166.4 | 168.0 | 42.5 | 48.9 | 173.9 | 106.3 | 56.8 | 19.4 | 5.4 | 3.6 |
| Operating Income | |||||||||||||
| Operating Income | (215.4) | (110.4) | (68.0) | (162.7) | (127.0) | (153.4) | (208.3) | (159.5) | (102.6) | (55.3) | (19.3) | (5.4) | (3.6) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.0 | – | 0.0 | 0.0 | 0.3 | 0.1 | 0.0 | 0 |
| Interest Income | 10.5 | 0 | 0 | 0 | 0.0 | 0 | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||||||||
| EBITDA | (195.5) | (101.7) | (58.8) | (152.6) | (117.2) | (145.3) | (200.7) | (153.9) | (100.2) | (54.9) | (18.6) | (5.1) | (3.3) |
| EBIT | (204.4) | (110.4) | (68.0) | (162.7) | (127.0) | (153.4) | (208.3) | (159.5) | (102.4) | (55.7) | (19.3) | (5.1) | (3.5) |
| Income Before Tax | (204.4) | (97.0) | (58.2) | (161.1) | (122.4) | (150.8) | (193.6) | (146.6) | (101.3) | (54.8) | (19.2) | (5.1) | (3.6) |
| Income Tax Expense | 0 | 0 | (0.7) | 0.7 | (0.2) | (0.8) | 0 | 0.1 | 0.7 | 0.6 | 0.0 | 0.1 | (0.3) |
| Net Income | (204.4) | (97.0) | (57.5) | (161.8) | (122.2) | (149.9) | (193.6) | (146.7) | (102.0) | (55.4) | (19.2) | (5.2) | (3.3) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | -5.30 | -5.06 | -3.85 | -2.43 | -0.89 | -0.25 | -0.93 |
| EPS (Diluted) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | -5.30 | -5.06 | -3.85 | -2.43 | -0.89 | -0.25 | -0.93 |
| Shares Outstanding | 168.6 | 138.3 | 106.1 | 78.9 | 51.8 | 39.2 | 33.9 | 29.0 | 26.5 | 22.8 | 21.6 | 20.9 | 3.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 602.1 | 302.1 | 200.4 | 88.5 | 150.6 | 184.5 | 147.2 | 174.8 | 142.5 | 150.3 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.3 | 1.4 | 21.1 | 0 | 0 | 30 | 20 | 10 | 1 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 11.5 | 7.3 | 4.0 | 2.1 | 5.4 | 5.1 | 8.7 | 10.9 | 0 | 1.7 |
| Total Current Assets | 614.8 | 320.4 | 235.4 | 98.5 | 162.6 | 230.0 | 185.5 | 202.3 | 150.5 | 152.0 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 19.9 | 28.0 | 35.7 | 44.1 | 40.6 | 45.4 | 54.5 | 39.9 | 27.3 | 8.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 3.8 | 0 | 0 | 0 | 0 | 3.7 | 33.6 | 53.6 | 3.6 | 3.6 |
| Other Non-Current Assets | 0.0 | 3.8 | 3.9 | 3.7 | 3.8 | 0.1 | 10.7 | 0.1 | 0.4 | 3.7 |
| Total Non-Current Assets | 23.7 | 31.8 | 39.6 | 47.8 | 44.4 | 49.2 | 98.8 | 93.7 | 31.4 | 12.8 |
| Total Assets | 638.5 | 352.2 | 274.9 | 146.4 | 207.0 | 279.2 | 284.2 | 295.9 | 181.8 | 164.8 |
| Current Liabilities | ||||||||||
| Account Payables | 15.7 | 16.3 | 12.8 | 16.9 | 7.3 | 13.8 | 9.1 | 13.1 | 7.6 | 4.9 |
| Short-Term Debt | 8.4 | 0 | 0 | 0 | 0 | 3.7 | 3.2 | 1.2 | 0 | 0.1 |
| Deferred Revenue | 44.4 | 66.0 | 150.1 | 31.6 | 37.1 | 91.6 | 89.7 | 100.9 | 2.7 | 2.7 |
| Other Current Liabilities | 26.6 | 15.4 | 14.1 | 12.3 | 10.2 | 3.0 | 7.5 | 6.5 | 1.3 | 3.4 |
| Total Current Liabilities | 95.1 | 111.0 | 186.4 | 71.5 | 64.2 | 121.0 | 118.2 | 130.0 | 19.6 | 12.2 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.2 | 3.1 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68.2 | 1.4 | 0.0 |
| Other Non-Current Liabilities | 0 | 7.9 | 7.9 | 8.1 | 7.9 | 0.5 | 1.7 | 5.9 | 10.6 | 1.6 |
| Total Non-Current Liabilities | 17.2 | 31.7 | 48.9 | 120.0 | 110.3 | 67.5 | 94.5 | 92.6 | 22.4 | 17.8 |
| Total Liabilities | 112.3 | 142.7 | 235.3 | 191.5 | 174.5 | 188.6 | 212.6 | 222.6 | 42.0 | 29.9 |
| Stockholders' Equity | ||||||||||
| Common Stock | 1,616.5 | 1,175.2 | 935.4 | 802.8 | 749.9 | 694.1 | 539.5 | 375.1 | 310.0 | 215.6 |
| Retained Earnings | (1,326.2) | (1,121.9) | (1,024.8) | (967.3) | (805.5) | (683.3) | (533.4) | (339.7) | (192.5) | (90.5) |
| Accumulated Other Comprehensive Income | (0.2) | (0.3) | (0.1) | (0.0) | 0.2 | 0.4 | 0.3 | 0.2 | 0.1 | (0.3) |
| Total Stockholders' Equity | 526.2 | 209.5 | 39.6 | (45.1) | 32.5 | 90.7 | 71.6 | 73.3 | 139.8 | 134.9 |
| Total Liabilities & Equity | 638.5 | 352.2 | 274.9 | 146.4 | 207.0 | 279.2 | 284.2 | 295.9 | 181.8 | 164.8 |
| Debt Metrics | ||||||||||
| Total Debt | 17.8 | 25.4 | 32.1 | 37.6 | 29.9 | 29.3 | 32.5 | 10.4 | 3.5 | 0.1 |
| Net Debt | (584.3) | (276.7) | (168.2) | (50.9) | (120.6) | (155.2) | (114.6) | (164.4) | (139.0) | (150.2) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (204.4) | (97.0) | (57.5) | (161.8) | (122.2) | (149.9) | (193.6) | (146.7) | (102.0) | (55.4) |
| Depreciation & Amortization | 8.9 | 8.7 | 9.2 | 10.1 | 9.8 | 10.0 | 9.2 | 5.6 | 2.2 | 0.8 |
| Stock-Based Compensation | 0 | 13.1 | 9.8 | 17.2 | 16.4 | 14.3 | 19.5 | 15.6 | 12.1 | 6.8 |
| Change in Working Capital | (16.9) | (75.8) | 19.1 | 6.7 | 7.0 | 9.6 | (23.3) | 102.4 | (0.3) | 16.2 |
| Other Non-Cash Items | 25.0 | 0 | 0 | 0.0 | 12.6 | 9.1 | 0 | 0.2 | 3.6 | 0.6 |
| Operating Cash Flow | (187.5) | (151.0) | (19.4) | (127.8) | (89.0) | (116.0) | (188.2) | (22.9) | (83.7) | (31.9) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.7) | (0.9) | (1.1) | (1.4) | (0.6) | (1.3) | (3.9) | (9.9) | (18.9) | (5.6) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 |
| Purchases of Investments | 0 | 0 | 0 | (75.0) | 0 | 0 | 0 | 0 | 0 | (2.6) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 75.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 | (9.9) | (0.0) | (2.6) |
| Investing Cash Flow | (0.7) | (0.9) | (1.1) | (1.3) | (0.6) | (1.3) | (3.9) | (9.9) | (18.9) | (8.2) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.1) | (0.1) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 17.7 | 1.3 | 14.9 | 0.9 | 0.9 | 2.6 | 5.1 | 0.9 | (0.8) |
| Financing Cash Flow | 488.2 | 253.9 | 132.5 | 67.2 | 55.8 | 154.5 | 164.4 | 65.1 | 94.4 | 29.1 |
| Cash Position | ||||||||||
| Net Change in Cash | 300.0 | 101.8 | 111.9 | (62.1) | (33.9) | 37.3 | (27.6) | 32.3 | (7.8) | (10.9) |
| Cash at Beginning | 302.1 | 204.1 | 92.2 | 154.2 | 188.1 | 150.8 | 178.4 | 146.1 | 150.3 | 161.2 |
| Cash at End | 602.1 | 305.8 | 204.1 | 92.2 | 154.2 | 188.1 | 150.8 | 178.4 | 142.5 | 150.3 |
| Free Cash Flow | (187.5) | (152.0) | (20.5) | (129.1) | (89.6) | (117.3) | (192.1) | (32.8) | (102.6) | (37.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 42.7 | 108.3 | 113.3 | 3.6 | 41.0 | 20.1 | 16.0 | 14.4 | 3.7 | 1.5 | 0.2 | 0 | 0 |
| Gross Profit | 33.9 | 108.3 | 113.3 | 3.6 | 41.0 | (110.9) | (159.4) | (120.0) | (75.6) | 1.1 | (8.9) | (2.4) | (4.6) |
| Operating Income | (215.4) | (110.4) | (68.0) | (162.7) | (127.0) | (153.4) | (208.3) | (159.5) | (102.6) | (55.3) | (19.3) | (5.4) | (3.6) |
| Net Income | (204.4) | (97.0) | (57.5) | (161.8) | (122.2) | (149.9) | (193.6) | (146.7) | (102.0) | (55.4) | (19.2) | (5.2) | (3.3) |
| EPS (Diluted) | -1.21 | -0.70 | -0.54 | -2.05 | -2.36 | -3.82 | -5.30 | -5.06 | -3.85 | -2.43 | -0.89 | -0.25 | -0.93 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 602.1 | 302.1 | 200.4 | 88.5 | 150.6 | 184.5 | 147.2 | 174.8 | 142.5 | 150.3 | |||
| Total Assets | 638.5 | 352.2 | 274.9 | 146.4 | 207.0 | 279.2 | 284.2 | 295.9 | 181.8 | 164.8 | |||
| Total Debt | 17.8 | 25.4 | 32.1 | 37.6 | 29.9 | 29.3 | 32.5 | 10.4 | 3.5 | 0.1 | |||
| Stockholders' Equity | 526.2 | 209.5 | 39.6 | (45.1) | 32.5 | 90.7 | 71.6 | 73.3 | 139.8 | 134.9 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (187.5) | (151.0) | (19.4) | (127.8) | (89.0) | (116.0) | (188.2) | (22.9) | (83.7) | (31.9) | |||
| Capital Expenditure | (0.7) | (0.9) | (1.1) | (1.4) | (0.6) | (1.3) | (3.9) | (9.9) | (18.9) | (5.6) | |||
| Free Cash Flow | (187.5) | (152.0) | (20.5) | (129.1) | (89.6) | (117.3) | (192.1) | (32.8) | (102.6) | (37.4) | |||